Zydus Lifesciences Gets 4 US FDA Observations for Baddi Plant

Zydus Lifesciences Ltd. has received four observations from the US Food and Drug Administration for its formulations plant in Baddi, Himachal Pradesh.

The US regulator carried out a surveillance inspection at the facility from August 4-13. Zydus said the observations were not related to data integrity and it will work closely with the regulator to address them.